在视网膜病变和视神经病变的基因和细胞治疗中,iPSC的潜力和应用
E V Lapshin1, Y G Gershovich1, A V Karabelsky1
1Gene Therapy Department, Science Center for Translational Medicine, Sirius University of Science and Technology, Krasnodar Region, Sirius, 354340 Russian Federation.
Acta naturae
|January 18, 2024
概括
诱导多能干细胞 (iPSC) 为研究遗传性神经病变和视网膜病变提供了有前途的体外模型. 这些模型有助于开发新的治疗策略,以恢复视觉功能.
科学领域:
- 眼科医生 眼科 眼科
- 干细胞生物学 干细胞生物学
- 再生医学是一种再生医学.
背景情况:
- 遗传性神经病变和视网膜病变是导致视力丧失的主要原因.
- 视网膜质细胞的退化和视神经缩导致神经病变.
- 光受体或视网膜色素表皮损伤导致视网膜病变.
研究的目的:
- 审查诱导多能干细胞 (iPSCs) 在体外疾病建模中的使用.
- 探索使用iPSCs治疗光学病理的治疗策略.
- 为了突出从iPSCs的视网膜有机体发育的进步.
主要方法:
- 对利用人类iPSCs用于疾病建模的研究的文献综述.
- 分析iPSC衍生的视网膜和质器官.
- 在基于iPSC的疗法中检查基因编辑应用.
主要成果:
- 人类iPSC可以作为研究视觉神经病变的有效模型,如玻璃眼和勒伯遗传性视觉神经病变.
- 来自iPSC的视网膜有机体显示出疾病病理学研究的潜力.
- 基因编辑工具与iPSC相结合,显示出治疗开发的前景.
结论:
- iPSCs是了解遗传性视神经病变和视网膜病变的病变发生的宝贵工具.
- 基于iPSC的体外模型和器官有助于开发新疗法.
- 未来的研究方向包括完善iPSC模型和推进用于视力恢复的基因编辑疗法.
更多相关视频
相关概念视频
Induced Pluripotent Stem Cells
23.1K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
23.1K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K


